Dermata Therapeutics (DRMA) Q3 2024 Earnings

7AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-5.4
-3.67
-1.94
-0.21

Details

Expected EPS
-3.79
Actual EPS
-4.18
Surprise EPS
-0.39
Surprise Percent
+10.29%

Description

Dermata Therapeutics (DRMA) has reported earnings of -4.18 per share for Q3 2024.

0 Comments

Share your thoughts